Redx nominates oral porcupine inhibitor RXC-006 as development compound to treat IPF Nov. 15, 2018 No Comments
FDA approves Oralair to treat grass pollen-induced allergic rhinitis in pediatric patients Nov. 14, 2018 No Comments
CF-MEV-132 reduces lung damage in rat model of hyperoxia-induced bronchopulmonary dysplasia Nov. 7, 2018 No Comments
VX-659/tezacaftor/ivacaftor triple combination regimen shows safety and efficacy in phase II study Nov. 6, 2018 No Comments
RSS